Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer's disease.
Jan 6, 2023
0
6
Amyloid plaques are protein deposits that collect between brain cells, hindering function and eventually leading to neuronal death. They are considered a hallmark of Alzheimer's disease (AD), and the focus of multiple investigations ...
Aug 23, 2021
0
263
(HealthDay)—As researchers hone in on ways to detect whether someone has a high risk of developing Alzheimer's disease before they have any symptoms, mental health professionals have worried what the psychological fallout ...
Aug 11, 2020
0
4
In recent years, scientists have conducted more than 100 clinical trials in the hopes of finding new indicators capable of diagnosing Alzheimer's disease prior to the manifestation of clinical symptoms such as memory loss. ...
Apr 8, 2020
1
84
A hypothesis which has been the standard way of explaining how the body develops Alzheimer's Disease for almost 30 years is flawed, according to a University of Manchester biologist.
Oct 16, 2018
0
197
Lifetime risks of developing Alzheimer's disease dementia vary considerably by age, gender and whether any signs or symptoms of dementia are present, according to a new study published online by Alzheimer's & Dementia.
May 22, 2018
0
5
Using two complementary approaches to reduce the deposits of amyloid-beta in the brain rather than either approach alone improved spatial navigation and memory in a mouse model of Alzheimer's disease. These findings suggest ...
Apr 11, 2018
0
15
Taking menopausal hormone therapy soon after menopause to relieve symptoms may also benefit the brain, according to a study published in the March 21, 2018, online issue of Neurology, the medical journal of the American Academy ...
Mar 21, 2018
0
6
You're about to turn 60, and you're fretting. Your mother has had Alzheimer's disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person ...
Feb 26, 2018
0
14
A team of researchers from the Cleveland Clinic Lerner Research Institute have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer's ...
Feb 14, 2018
0
3943
